Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
83.00    0.40 (0.48%)
Bid:
82.00
Ask:
84.00
Spread: 2.00 (2.439%)
Market Cap: £87.21m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

Acquisition

2 Dec 2019 07:00

RNS Number : 2338V
SDI Group PLC
02 December 2019
 

SDI Group plc

 ("SDI", the "Company" or the "Group")

(AIM: SDI)

 

Acquisition of Chell Instruments Limited

The Board of SDI Group plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, is pleased to announce the acquisition on 29 November 2019 of Chell Instruments Limited ("Chell") for a consideration of £4.3m plus an additional cash payment for net assets at completion (the "Acquisition").

 

Highlights:

 

·; Chell specialises in the design, manufacture and calibration of pressure, vacuum and gas flow measurement instruments for a variety of sectors including aerospace, vehicle aerodynamics, gas and steam turbine testing and power generation industries

·; For the year ended 31 December 2018, Chell achieved revenue of £4.7m, gross profit of £2.5m and profit before tax of £0.78m

·; The Board has identified areas within Chell that have the potential for growth using the strong management team the company has recruited over the years

·; The Acquisition is expected to be earnings enhancing in its first full year of ownership

 

Ken Ford, Chairman of SDI said:

"Chell Instruments is another step in our Group growth strategy. It is a complementary fit providing potential areas for growth. The acquisition is in line with our previously announced strategy of organic and acquisitive growth and is expected to be earnings enhancing in its first full year of ownership."

 

About Chell Instruments Limited

Chell specialises in the design, manufacture and calibration of pressure, vacuum and gas flow measurement instruments for a variety of sectors including aerospace, vehicle aerodynamics, gas and steam turbine testing and power generation industries. Based in North Walsham in Norfolk, Chell was founded in 1976 and employs 34 staff. Of the 34 staff members, 30 are either fully qualified engineers or in training to achieve that status.

 

For the year ended 31 December 2018 Chell achieved revenues of £4.7m, gross profit of £2.5m and profit before tax of £0.78m. Revenues include service revenues calibrating in service Chell Instrumentation, and instrumentation made by others.

 

Approximately 76 per cent. of Chell's sales are to the UK with the balance of 24 per cent. being exported.

 

Chell's competitive advantages are its calibration laboratory, deep understanding of its customers' applications and its own manufacturing facility with industry leading capabilities.

 

Acquisition rationale

The Acquisition is in line with the Group's strategy of acquiring complementary businesses and the Board has identified areas within Chell that have the potential for growth. Chell will be part of SDI Group's Sensors and Control reporting segment.

Consideration for the Acquisition

Total cash consideration (excluding an additional cash payment for net assets at completion, expected to be less than £1.7m and such assets expected to include a material element of cash) is £4.3m. SDI has funded the cash consideration from existing cash resources and bank debt.

The Board also announces that, in agreement with HSBC Bank plc, it has taken a 3-year amortising term loan of £4.8m to add to the Senior Facility of £5m (not fully drawn), with the end date of both facilities being April 2023. The Group's unaudited net debt position at 31 October 2019 was £0.7m, before adjustment for the effects of reporting under IFRS 16 (Leases).

The Company expects to report its interim results for the six months to 31 October 2019 on 17 December 2019.

Enquiries

SDI Group plc 01223 320 480

Ken Ford, Chairman

Mike Creedon, CEO

Jon Abell, CFO

www.scientificdigitalimaging.com

 

finnCap Ltd 020 7220 0500

Ed Frisby/Kate Washington - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

JW Communications 07818 430 877

Julia Wilson - Investor & Public Relations

About SDI Group plc:

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries and Fistreem.

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.

No statement in this announcement is intended to be a profit forecast or estimate and no statement in this announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company.

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQLFFVILALAFIA
Date   Source Headline
24th Jan 20177:00 amRNSInterim Results
19th Jan 201712:54 pmRNSHolding(s) in Company
12th Jan 20179:35 amRNSHolding(s) in Company
11th Jan 201711:17 amRNSHolding(s) in Company
10th Jan 201712:05 pmRNSResult of General Meeting
20th Dec 20167:00 amRNSEquity Fundraising & Acquisition
23rd Sep 20163:20 pmRNSResult of AGM
22nd Jul 20167:00 amRNSFinal Results
11th Jul 20167:00 amRNSFurther guidance from DoH on contamination levels
24th May 20167:00 amRNSTrading Update
12th Jan 20163:57 pmRNSHolding(s) in Company
8th Jan 20167:00 amRNSHalf Yearly Report
5th Jan 20163:27 pmRNSHolding(s) in Company
17th Nov 20154:58 pmRNSHolding(s) in Company
17th Nov 20152:11 pmRNSHolding(s) in Company
13th Nov 201512:12 pmRNSResult of General Meeting
29th Oct 20151:44 pmRNSDirector Dealing
28th Oct 20155:36 pmRNSAcquisition, Equity Fundraising and Notice of GM
23rd Sep 20152:00 pmRNSResult of AGM
28th Jul 20157:00 amRNSFinal Results
26th May 20157:01 amRNSGuidance from DoH on contamination levels
14th May 20157:00 amRNSTrading Update
9th Feb 20151:00 pmRNSResult of General Meeting
15th Jan 20152:50 pmRNSDirector/PDMR Shareholding
15th Jan 20157:01 amRNSIssue of Equity and Notice of General Meeting
15th Jan 20157:00 amRNSHalf Yearly Report
23rd Sep 201411:54 amRNSResult of AGM
11th Aug 20147:00 amRNSFinal Results for the year ended 30 April 2014
1st Aug 20143:37 pmRNSTotal Voting Rights
20th May 20147:00 amRNSTrading update
1st May 20147:00 amRNSPXi Touch being used at University of Cambridge
10th Apr 20147:00 amRNSHolding(s) in Company
14th Mar 20147:00 amRNSExpansion of Imaging Systems range
14th Feb 20147:00 amRNSAcquisition of Opus Instruments
20th Dec 20137:00 amRNSHalf Yearly Report
14th Oct 20134:30 pmRNSHolding(s) in Company
17th Sep 20137:00 amRNSResult of AGM
29th Aug 20137:00 amRNSNotice of AGM - change of venue
25th Jul 201312:39 pmRNSDirector/PDMR Shareholding
24th Jul 201310:36 amRNSDirector/PDMR Shareholding
24th Jul 20137:01 amRNSRe ProReveal
24th Jul 20137:00 amRNSFinal Results
9th Jul 201311:26 amRNSResult of GM
21st Jun 201311:30 amRNSIssue of Equity, Trading Update and Notice of GM
7th Mar 20133:52 pmRNSCorrection re directors dealings announcements
8th Feb 20137:00 amRNSSale of ProtoCOL 3 Systems to Chinese SFDA
12th Dec 20124:32 pmRNSDirector/PDMR Shareholding
12th Dec 201212:43 pmRNSDirector/PDMR Shareholding
12th Dec 20127:00 amRNSUnaudited Interim Results to 31 October 2012
12th Dec 20127:00 amRNSSynoptics Health: ProReveal product launch update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.